Table 1. Summary of mutations over disease course.
Name of Mutation | Initial BM (Only PV) | PV transformation to AML | PV alone (AML in Remission) |
---|---|---|---|
JAK2-V617F | Not Done | Positive | Positive |
FLT3 | Not Done | Negative | Negative |
IDH1, IDH2 | Not Done | Negative | Negative |
KIT | Not Done | Negative | Negative |
KRAS, NRAS | Not Done | Negative | Negative |
NPM1 | Not Done | Negative | Negative |
DNMT3A | Not Done | Not Done | Positive |
TET2 | Not Done | Not Done | Positive |
Miscellaneous other mutations were tested in the bone marrow in remission for AML with presence of PV and were negative - ABL1, ASXL1, BRAF, EGFR, EZH2, FLT3, GATA1, GATA2, HRAS, IDH1, IDH2, IKZF2, KIT, KRAS, MDM2, MLL, MPL, MYD88, NOTCH1, NPM1, NRAS, PTPN11, RUNX1, TP53 and WT1 were not detected.